Perpetual LTD Eli Lilly & CO Transaction History

Perpetual LTD

$9.23 Trillion
Q3 2024

A detailed history of Perpetual LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Perpetual LTD holds 97,472 shares of LLY stock, worth $73.4 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

97,472

Previous 101,557 4.02%

Holding current value

$73.4 Million

Previous $91.9 Billion 6.08%

% of portfolio

0.94%

Previous 1.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$772.14 - $960.02 $3.15 Million - $3.92 Million	-4,085 Reduced 4.02%	97,472 $86.4 Billion
Q2 2024 Jul 30, 2024	SELL	$724.87 - $909.04 $13.3 Million - $16.7 Million	-18,319 Reduced 15.28%	101,557 $91.9 Billion
Q1 2024 Apr 09, 2024	SELL	$592.2 - $792.28 $18.5 Million - $24.7 Million	-31,210 Reduced 20.66%	119,876 $93.3 Billion
Q4 2023 Feb 15, 2024	BUY	$525.19 - $619.13 $77.2 Million - $91 Million	146,973 Added 3573.38%	151,086 $88.1 Billion
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $185,182 - $255,301	426 Added 11.55%	4,113 $2.21 Billion
Q2 2023 Jul 13, 2023	SELL	$350.74 - $468.98 $59,976 - $80,195	-171 Reduced 4.43%	3,687 $1.73 Billion
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $572,180 - $671,998	-1,842 Reduced 32.32%	3,858 $1.32 Billion
Q2 2020 Nov 18, 2020	BUY	$136.42 - $164.18 $777,593 - $935,826	5,700 New	5,700 $1.97 Million
Q1 2020 Nov 18, 2020	SELL	$119.05 - $147.35 $678,585 - $839,895	-5,700 Closed	0 $0
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $276,975 - $323,300	-2,500 Reduced 30.49%	5,700 $632,000
Q3 2018 Oct 30, 2018	SELL	$85.86 - $107.31 $283,338 - $354,123	-3,300 Reduced 28.7%	8,200 $880,000
Q2 2018 Jul 23, 2018	BUY	$75.7 - $86.88 $870,550 - $999,120	11,500 New	11,500 $983,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perpetual LTD, based on Form 13F filings with the SEC.

News

Stay updated on Perpetual LTD with notifications on news.

Account